Background The development of drug-resistant (DR) tuberculosis (TB) has become an
increasing concern over the past few decades as the result of numerous factors, including …

The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

A large burden of undiagnosed hepatitis virus cases remains globally. Despite the 257
million people living with chronic hepatitis B virus infection, and 71 million with chronic …

Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

The World Health Organization (WHO) has produced this WHO operational handbook on
tuberculosis to provide practical advice to complement the latest WHO consolidated …

Background Previously treated tuberculosis (TB) patients are a widely reported risk factor for
multidrug-resistant tuberculosis. Identifying patients' problems during treatment is necessary …

Background Decentralization is promoted as a strategy to improve health system
performance by bringing decision-making closer to service delivery. Some studies have …

Methods We conducted a scoping review to assess the impact of decentralized, integrated
and family-centred care on child and adolescent tuberculosis-related outcomes, describe …

The purpose of this study is to identify at what extent multidrug-resistant tuberculosis (MDR-
TB) diseases effect on environmental health issues in selected provinces of Chinese …

Background Patient-centered care is pillar 1 of the “End TB” strategy, but little has been
documented in the literature about what this means for people living with rifampicin-resistant …